Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Yong Yean Kim

Assistant Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (8)

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Benjamin Stanton

Assistant Professor

UNITED STATES

View details

Jong-In Park

Professor and Heider Endowed Chair in Cancer Research

Creighton University

UNITED STATES

View details

Silvia Pomella

RTT

University of Rome Tor Vergata

ITALY

View details

Jack Shern

Head, Tumor Evolution and Genomics Section

National Institutes of Health

UNITED STATES

View details

Mohamed Elsherif Badr

Assistant Professor, Principal Investigator

Chinese Institutes for Medical Research

CHINA

View details

Grégoire Altan-Bonnet

National Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yong Yean Kim

Research Interests

Explore related searches

Articles (8)

Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma

Gonystylones A-E, Antiproliferative 5,6-Dihydro-α-pyrones from the Plant Gonystylus borneensis.

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma

Neopetrotaurines A-C, Isoquinoline Alkaloids with an Unprecedented Taurine Bridge from the Sponge Neopetrosia sp.

A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.

Collaborators (6)

Benjamin Stanton

Jong-In Park

Silvia Pomella

Jack Shern

Mohamed Elsherif Badr

Grégoire Altan-Bonnet

Make your next move.